Primary study · included by 1 review
Efficacy of Subgingivally Delivered 1.2% Atorvastatin in the Treatment of Chronic Periodontitis in Patients With Type 2 Diabetes Mellitus: A Randomized Controlled Clinical Trial.
Kumari 2016 · Kumari Minal, Martande Santosh S, Pradeep A R, et al. · Journal of periodontology · 2016
Included by
| Outcome this study informs | Pooled effect | Evidence | Certainty |
|---|---|---|---|
Clinical attachment level (CAL), change from baseline (mm) SRP plus locally delivered 1.2% atorvastatin gel vs SRP alone (placebo gel or no gel) · 6 months | MD 1.70 [1.22, 2.19] | 6 studies · 332 participants | GRADE not reported |
Probing pocket depth (PPD), change from baseline (mm) SRP plus locally delivered 1.2% atorvastatin gel vs SRP alone (placebo gel or no gel) · 6 months | MD 1.39 [0.99, 1.79] | 6 studies · 332 participants | GRADE not reported |
1 including review in total.